PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsacute intermittent porphyria
MeSH D017118 - acute intermittent porphyria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017094:Hepatic porphyrias
1 Company
1 Drug
$
Success rate
D017118: 
Acute intermittent porphyria
37 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaChlorpromazine Chlorpromazine  1982-01-01   
Glenmark PharmaceuticalsChlorpromazine Chlorpromazine  2021-03-23   
GSKChlorpromazine Thorazine  1982-01-01   
Chartwell PharmaceuticalsChlorpromazine Chlorpromazine  1982-01-01   
Chlorpromazine Sonazine  1982-01-01   
WyethChlorpromazine Chlorpromazine  1982-01-01   
AlpharmaChlorpromazine Chlorpromazine  1982-01-01   
Genus LifesciencesChlorpromazine Chlorpromazine  2021-06-02   
PfizerChlorpromazine Promapar  1982-01-01   
Dr Reddys LaboratoriesChlorpromazine Chlorpromazine  1982-01-01   
Zydus TherapeuticsChlorpromazine Chlorpromazine  2020-01-17   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
67%
2/3
Phase 3
33%
1/3
Approved: 1Overall Success rate: 15%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use